Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)

Market Cap	26.13B +39.5%
Revenue (ttm)	613.24M +114.2%
Net Income	-277.82M
EPS	-0.27
Shares Out	1.03B
PE Ratio	n/a
Forward PE	275.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,429,753
Open	25.90
Previous Close	25.44
Day's Range	24.26 - 25.98
52-Week Range	14.58 - 35.34
Beta	1.51
Analysts	Strong Buy
Price Target	37.53 (+44.99%)
Earnings Date	Mar 26, 2026

About HKG:2252

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots in the People’s Republic of China. The company offers Toumai laparoscopic surgical robot; Toumai single port laparoscopic surgical robot; DFVision 3D electronic laparoscope; SkyWalker orthopedic surgical robot; trans-bronchial surgical robot for natural orifice surgery; R-ONE vascular interventional robot for pan vascular surgery; and iSR’obot Mona Lisa robotic trans perineal prostate biopsy system. It is also involved...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 464
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2252

Financial Performance

In 2025, HKG:2252's revenue was 551.07 million, an increase of 114.22% compared to the previous year's 257.25 million. Losses were -249.66 million, -61.14% less than in 2024.

Financial numbers in CNY